Skip to main content
SpringerLink
Log in

100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

To determine whether published disease penetrance estimates of 50% for pheochromocytoma and 20–30% for primary hyperparathyroidism in multiple endocrine neoplasia (MEN 2A), conceivably reflecting overrepresentation of index patients with completely developed MEN 2A, may be too high.

Methods

Cross-sectional study of carriers at high risk of MEN 2A from a tertiary referral center.

Results

There were 213 carriers of RET mutations in codon 634, born between 1922 and 2014. Median age of thyroidectomy was 17 years, with MTC being present in 76.5%; pheochromocytoma in 31.0% at a median of 34 years in the first, and in 18.8% at a median of 35 years in the second adrenal; and primary hyperparathyroidism in 10.8% at a median of 39 years. MTC, pheochromocytoma and primary hyperparathyroidism, stratified by year of birth, were diagnosed earlier over time: for MTC from 51 to 4 years; for pheochromocytoma from 51 to 22.5 years in the first, and from 51 to 29.5 years in the second adrenal, and for primary hyperparathyroidism from 46 to 12 years (P ≤ 0.008). This decline in age was paralleled by diminishing tumor diameters, more strongly in the thyroid (from 20 to 1.8 mm; P < 0.001) than in the adrenals (from 43 to 30 mm in the first, and from 20–57.5 to 30.5 mm in the second adrenal; statistically nonsignificant).

Conclusions

The lower disease penetrance estimates and sluggish decline of adrenal tumor diameters call for more widespread adoption of adrenal-sparing and parathyroid preservation surgery based on early and regular biochemical screening.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. E.E. Eichler, Genetic variation, comparative genomics, and the diagnosis of disease. N. Engl. J. Med. 381, 64–74 (2019)

    Article  CAS  Google Scholar 

  2. A. Machens, H. Dralle, Long-term outcome after DNA-based prophylactic neck surgery in children at risk of hereditary medullary thyroid cancer. Best. Pract. Res. Clin. Endocrinol. Metab. 33, 101274 (2019)

    Article  Google Scholar 

  3. A. Machens, K. Lorenz, C. Sekulla, W. Höppner, K. Frank-Raue, F. Raue, H. Dralle, Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium. Eur. J. Endocrinol. 168, 307–314 (2013)

    Article  CAS  Google Scholar 

  4. S.A. Wells Jr, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, N. Lee, A. Machens, J.F. Moley, F. Pacini, F. Raue, K. Frank-Raue, B. Robinson, M.S. Rosenthal, M. Santoro, M. Schlumberger, M. Shah, S.G. Waguespack, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma, Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25, 567–610 (2015)

    Article  Google Scholar 

  5. A. Machens, K. Lorenz, F. Weber, H. Dralle, Genotype-specific progression of hereditary medullary thyroid cancer. Hum. Mutat. 39, 860–869 (2018)

    Article  CAS  Google Scholar 

  6. C.J. Lips, R.M. Landsvater, J.W. Höppener, R.A. Geerdink, G. Blijham, J.M. van Veen, A.P. van Gils, M.J. de Wit, R.A. Zewald, M.J. Berends, F.A. Beemer, J. Brouwers-Smalbraak, R.P. Jansen, H.K. Ploos van Amstel, T.J. van Vroonhoven, T.M. Vroom, Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N. Engl. J. Med. 331, 828–835 (1994)

    Article  CAS  Google Scholar 

  7. S.A. Wells Jr, D.D. Chi, K. Toshima, L.P. Dehner, C.M. Coffin, S.B. Dowton, J.L. Ivanovich, M.K. DeBenedetti, W.G. Dilley, J.F. Moley, J.A. Norton, H. Donis-Keller, Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann. Surg. 220, 237–247 (1994)

    Article  Google Scholar 

  8. C. Eng, D. Clayton, I. Schuffenecker, G. Lenoir, G. Cote, R.F. Gagel, H.K. van Amstel, C.J. Lips, I. Nishisho, S.I. Takai, D.J. Marsh, B.G. Robinson, K. Frank-Raue, F. Raue, F. Xue, W.W. Noll, C. Romei, F. Pacini, M. Fink, B. Niederle, J. Zedenius, M. Nordenskjöld, P. Komminoth, G.N. Hendy, H. Gharib, S.N. Thibodeau, A. Lacroix, A. Frilling, B.A.J. Ponder, L.M. Mulligan, The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276, 1575–1579 (1996)

    Article  CAS  Google Scholar 

  9. H. Dralle, O. Gimm, D. Simon, K. Frank-Raue, G. Görtz, B. Niederle, R.A. Wahl, B. Koch, S. Walgenbach, R. Hampel, M.M. Ritter, F. Spelsberg, A. Heiss, R. Hinze, W. Höppner, Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J. Surg. 22, 744–750 (1998). discussion 750–751

    Article  CAS  Google Scholar 

  10. A. Machens, P. Niccoli-Sire, J. Hoegel, K. Frank-Raue, T.J. van Vroonhoven, H.D. Roeher, R.A. Wahl, P. Lamesch, F. Raue, B. Conte-Devolx, H. Dralle, European Multiple Endocrine Neoplasia (EUROMEN) Study Group, Early malignant progression of hereditary medullary thyroid cancer. N. Engl. J. Med. 349, 1517–1525 (2003)

    Article  CAS  Google Scholar 

  11. A. Machens, H. Dralle, Advances in risk-oriented surgery for multiple endocrine neoplasia type 2. Endocr. Relat. Cancer 25, T41–52 (2018)

    Article  CAS  Google Scholar 

  12. J.S. Mathiesen, J.P. Kroustrup, P. Vestergaard, K. Stochholm, P.L. Poulsen, Å.K. Rasmussen, U. Feldt-Rasmussen, S. Schytte, S.C. Londero, H.B. Pedersen, C.H. Hahn, B.D. Djurhuus, J. Bentzen, S. Möller, M. Gaustadnes, M. Rossing, F.C. Nielsen, K. Brixen, A.L. Frederiksen, C. Godballe, Danish Thyroid Cancer Group (DATHYRCA), Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study. Endocr. Connect 7, 829–839 (2018)

    Article  Google Scholar 

  13. A. Machens, H. Dralle, Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J. Clin. Endocrinol. Metab. 95, 2655–2663 (2010)

    Article  CAS  Google Scholar 

  14. R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng, (eds) Pathology and genetics of tumours of endocrine organs 3rd edn. (World Health Organization, New York, NY, 2004)

  15. A. Machens, K. Lorenz, H. Dralle, Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels. Ann. Surg. 250, 305–310 (2009)

    Article  Google Scholar 

  16. A. Machens, H. Dralle, Therapeutic effectiveness of screening for multiple endocrine neoplasia type 2A. J. Clin. Endocrinol. Metab. 100, 2539–2545 (2015)

    Article  CAS  Google Scholar 

  17. H. Dralle, G.F. Scheumann, J. Kotzerke, E.G. Brabant, Surgical management of MEN 2. Recent Results Cancer Res. 125, 167–195 (1992)

    Article  CAS  Google Scholar 

  18. M. Brauckhoff, O. Gimm, P.N. Thanh, A. Bär, J. Ukkat, K. Brauckhoff, T. Bönsch, H. Dralle, Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy. Surgery 134, 1020–1027 (2003)

    Article  Google Scholar 

  19. L. Yip, J.E. Lee, S.E. Shapiro, S.G. Waguespack, S.I. Sherman, A.O. Hoff, R.F. Gagel, J.F. Arens, D.B. Evans, Surgical management of hereditary pheochromocytoma. J. Am. Coll. Surg. 198, 525–534 (2004)

    Article  Google Scholar 

  20. F. Castinetti, X.P. Qi, M.K. Walz, A.L. Maia, G. Sansó, M. Peczkowska, K. Hasse-Lazar, T.P. Links, S. Dvorakova, R.A. Toledo, C. Mian, M.J. Bugalho, N. Wohllk, O. Kollyukh, L. Canu, P. Loli, S.R. Bergmann, J. Biarnes Costa, O. Makay, A. Patocs, M. Pfeifer, N.S. Shah, T. Cuny, M. Brauckhoff, B. Bausch, E. von Dobschuetz, C. Letizia, M. Barczynski, M.K. Alevizaki, M. Czetwertynska, M.U. Ugurlu, G. Valk, J.T. Plukker, P. Sartorato, D.R. Siqueira, M. Barontini, M. Szperl, B. Jarzab, H.H. Verbeek, T. Zelinka, P. Vlcek, S.P. Toledo, F.L. Coutinho, M. Mannelli, M. Recasens, L. Demarquet, L. Petramala, S. Yaremchuk, D. Zabolotnyi, F. Schiavi, G. Opocher, K. Racz, A. Januszewicz, G. Weryha, J.F. Henry, T. Brue, B. Conte-Devolx, C. Eng, H.P. Neumann, Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Lancet Oncol. 15, 648–655 (2014)

    Article  Google Scholar 

  21. H.P.H. Neumann, U. Tsoy, I. Bancos, V. Amodru, M.K. Walz, A. Tirosh, R.J. Kaur, T. McKenzie, X. Qi, T. Bandgar, R. Petrov, M.Y. Yukina, A. Roslyakova, A.N.A. van der Horst-Schrivers, A.M.A. Berends, A.O. Hoff, L.A. Castroneves, A.M. Ferrara, S. Rizzati, C. Mian, S. Dvorakova, K. Hasse-Lazar, A. Kvachenyuk, M. Peczkowska, P. Loli, F. Erenler, T. Krauss, M.Q. Almeida, L. Liu, F. Zhu, M. Recasens, N. Wohllk, E.P.M. Corssmit, Z. Shafigullina, J. Calissendorff, S. Grozinsky-Glasberg, T. Kunavisarut, C. Schalin-Jäntti, F. Castinetti, P. Vlcek, D. Beltsevich, V.I. Egorov, F. Schiavi, T.P. Links, R.M. Lechan, B. Bausch, W.F. Young Jr, C. Eng; International Bilateral-Pheochromocytoma-Registry Group, Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy. JAMA Netw. Open 2, e198898 (2019). https://doi.org/10.1001/jamanetworkopen.2019.8898

    Article  PubMed  PubMed Central  Google Scholar 

  22. L.M. Gruber, R.P. Hartman, G.B. Thompson, T.J. McKenzie, M.L. Lyden, B.M. Dy, W.F. Young, I. Bancos, Pheochromocytoma characteristics and behavior differ depending on method of discovery. J. Clin. Endocrinol. Metab. 104, 1386–1393 (2019)

    Article  Google Scholar 

  23. A. Scholten, G.D. Valk, D. Ulfman, I.H. Borel Rinkes, M.R. Vriens, Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy. Ann. Surg. 254, 1022–1027 (2011)

    Article  Google Scholar 

  24. K.J. Rowland, R.D. Chernock, J.F. Moley, Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening. J. Surg. Oncol. 108, 203–206 (2013)

    Article  Google Scholar 

  25. A. Machens, K. Lorenz, H. Dralle, Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening. J. Clin. Endocrinol. Metab. 98, E336–E345 (2013)

    Article  CAS  Google Scholar 

  26. H.P.H. Neumann, W.F. Young Jr, C. Eng, Pheochromocytoma and paraganglioma. N. Engl. J. Med. 381, 552–565 (2019)

    Article  CAS  Google Scholar 

  27. P.K. Magalhães, S.R. Antonini, F.J. de Paula, L.C. de Freitas, L.M. Maciel, Primary hyperparathyroidism as the first clinical manifestation of multiple endocrine neoplasia type 2A in a 5-year-old child. Thyroid 21, 547–550 (2011)

    Article  Google Scholar 

  28. I. Schuffenecker, N. Ginet, D. Goldgar, C. Eng, B. Chambe, A. Boneu, C. Houdent, D. Pallo, M. Schlumberger, C. Thivolet, G.M. Lenoir, Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe d’Etude des Tumeurs à Calcitonine. J. Clin. Endocrinol. Metab. 83, 487–491 (1998)

  29. E. Korpershoek, B.J. Petri, E. Post, C.H. van Eijck, R.A. Oldenburg, E.J. Belt, W.Wde Herder, R.R. de Krijger, W.N. Dinjens, Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndrome. Neoplasia 16, 868–873 (2014)

    Article  Google Scholar 

  30. A. Machens, H. Dralle, Variability in penetrance of multiple endocrine neoplasia 2A with amino acid substitutions in RET codon 634. Clin. Endocrinol. 84, 210–215 (2016)

    Article  CAS  Google Scholar 

  31. L. Mucha, G. Leidig-Bruckner, K. Frank-Raue, T. Bruckner, M. Kroiss, F. Raue, German study group for rare thyroid cancer, Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades. Clin. Endocrinol. 87, 320–326 (2017)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Faculty, Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, D-06097, Halle (Saale), Germany

    Andreas Machens, Malik Elwerr, Kerstin Lorenz & Henning Dralle

  2. Department of General, Visceral and Transplantation Surgery, Section of Endocrine Surgery, University of Duisburg-Essen, D-45122, Essen, Germany

    Frank Weber & Henning Dralle

Authors
  1. Andreas Machens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Malik Elwerr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kerstin Lorenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Frank Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Henning Dralle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Machens.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Machens, A., Elwerr, M., Lorenz, K. et al. 100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A. Endocrine 68, 368–376 (2020). https://doi.org/10.1007/s12020-020-02232-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-020-02232-5

Keywords

Search

Navigation